-
Mashup Score: 4First study to detect Delta variant of SARS-CoV-2 in maternal bloodstream and placenta in cases of stillbirth and pregnancy complications - 2 year(s) ago
If you want to do the best thing for your baby, get vaccinated. Andrea Edlow, MD Maternal-Fetal Medicine, Massachusetts General Hospital BOSTON – A growing body of evidence has linked the Delta variant of SARS-CoV-2, the virus that causes COVID-19, with an increased risk for pregnancy complications, including stillbirths. Now, for the first time, researchers at Massachusetts General Hospital…
Source: Massachusetts General HospitalCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 265Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California - 2 year(s) ago
Background: The Omicron (B.1.1.529) variant of SARS-CoV-2 has rapidly achieved global dissemination, accounting for most infections in the United States by December 2021. Risk of severe outcomes associated with Omicron infections, as compared to earlier SARS-CoV-2 variants, remains unclear. Methods: We analyzed clinical and epidemiologic data from cases testing positive for SARS-CoV-2 infection…
Source: medRxivCategories: Latest Headlines, PulmonologyTweet-
NEW: Study on severity of those infected with the #OmicronVariant compared to the #DeltaVariant: ⬇️53% less risk of symptomatic hospitalization ⬇️74% less risk of ICU admission ⬇️91% less risk of death 0⃣Omicron patients required mechanical ventilation https://t.co/to2swFYF5Q https://t.co/LZYf0t3CGY
-
-
Mashup Score: 41
The strain is being called “deltacron.”
Source: CNBCCategories: Hem/Oncs, Latest HeadlinesTweet-
I want off this #pandemic ride, & I want my money back too. Who's with me? #MedTwitter #Cyprus reportedly discovers a #CovidVariant that combines #omicron and #DeltaVariant. https://t.co/khJXvx9cRo
-
-
Mashup Score: 18
A team of researchers affiliated with a host of institutions in South Africa has found evidence that suggests people who have been infected with the COVID-19 Omicron variant may be less susceptible to infection from the Delta variant. The team has written a paper describing their work.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet-
Study shows people infected with #Omicron may be less susceptible to #Deltavariant https://t.co/4WRkuzesLr
-
-
Mashup Score: 9
CORBEVAX was developed and engineered at Texas Children’s Center for Vaccine Development and Baylor College of Medicine with the purpose to vaccinate underserved countries. Developers said this new vaccine is most likely the lowest cost COVID-19 vaccine.(Photo courtesy: Texas Children’s Hospital) Mass distribution of a new COVID-19 vaccine made in Houston will be deployed to India…
Source: cbsaustin.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
/WATCH/READ/ New #COVID19 vaccine made in Texas receives emergency use authorization in #India @cbsaustin ⭐️This inexpensive #vaccine was developed by @PeterHotez & @mebottazzi of @bcmhouston specifically to address world #health #DeltaVariant #Omicron https://t.co/l7bcfM9IvX https://t.co/jCuqtM0mEG
-
-
Mashup Score: 2CDC Warns Omicron Wave Is Coming: When It Could Peak in US - 2 year(s) ago
The CDC announced that the Omicron variant is spreading so rapidly that it may trigger a massive wave of infections that peaks in January.
Source: HealthlineCategories: Healthcare Professionals, Latest HeadlinesTweet-
#Deltavariant accounts for 97% of all #COVID19 cases currently and #Omicronvariant is 3% #CDC Warns #Omicron Wave Is Coming: When It Could Peak in U.S. https://t.co/ZiKekRL34N
-
-
Mashup Score: 20How to contribute - 2 year(s) ago
Use this Google Form to record donations Donate to a food bank or hunger organization of your choice between December 13 and 19, 2021 – any amount helps! Feeding America can help you choose l…
Source: HealthCareWorkers vs HungerCategories: Hem/Oncs, Latest HeadlinesTweet-
If you cannot afford to donate, no worries at all. I’ll still be here for you for #Omicron & beyond. A great thanks would be to RT to help me spread the word re #HCWvsHunger & Team #Feedalizumab to your family & friends. 🙏 https://t.co/0WhCDKWOQP FAQs: https://t.co/pMUvWMGMFl
-
If you’ve been following me for #COVID19 & #DeltaVariant & #Omicron, I’d be so touched if you’d donate any amt to a food bank & log it here on behalf of our oncology team #Feedalizumab: https://t.co/0WhCDKWOQP. We’re raising money to keep folks fed in this #pandemic. #medtwitter
-
I have 35,402 followers. If each of you donated $10 to a food bank of your choice on behalf of #HCWvsHunger’s oncology team called #Feedalizumab, we’d raise $354,020, win this year’s competition, AND feed a ton of folks. https://t.co/0WhCDKWOQP FAQs: https://t.co/pMUvWMGMFl https://t.co/dYyOAJlKyR
-
Literally took an entire week of vacation just to hype #HCWvsHunger. 😅 Please donate & help #MedTwitter #OncTwitter fight hunger on behalf of Team #Feedalizumab: https://t.co/0WhCDKWOQP. (Note that I also haven’t even started #ChristmasShopping either. 😩) https://t.co/C8UtbARuM5
-
-
Mashup Score: 5What Actually Worries U.S. Doctors About Omicron - 2 year(s) ago
As the Omicron variant spreads in the U.S. doctors and nurses are already overwhelmed and the health system facing huge pressure
Source: TimeCategories: Healthcare Professionals, Latest HeadlinesTweet-
But #deltavariant still hasn’t yet run its course in the US. I can’t even begin to imagine two contemporaneous surges -! The healthcare system is already facing the edge. https://t.co/tcA3Ln0eOe w/ @JosephSakran
-
-
Mashup Score: 4The COVID Digest, 11Dec2021 - 2 year(s) ago
The Thanksgiving Effect is here
Source: amberschmidtkephd.substack.comCategories: Infectious Disease, Latest HeadlinesTweet-
The COVID Digest, 11Dec2021 https://t.co/GiTD3TcTnx. As @AmberSchmidtke points out, the Thanksgiving effect is here. No need for Omicron to cause havoc, we have the #DeltaVariant which is bad enough. Please get vaccinated and get boosted if fully vaccinated.
-
-
Mashup Score: 127Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Booster Dose to 16- and 17-Year-Olds - 2 year(s) ago
The FDA authorized the use of a single booster dose of the Pfizer-BioNTech COVID-19 vaccine for individuals 16 and 17 years of age.
Categories: Latest Headlines, Oncologists1Tweet-
📣 BREAKING: #FDA has expanded use of Pfizer-BioNTech #COVID19 #BoosterShots to teens 16-17y who are 6+ mos after dose 2, concluding that immunity is waning & benefit>risk for this age group just as in 18+. #MedTwitter #GetBoosted #Omicron #DeltaVariant https://t.co/rpnyK1AZOE
-
Today, we amended the EUA for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the use of a single booster dose for individuals 16-17 years old at least six months after completion of primary vaccination with the Pfizer-BioNTech COVID-19 Vaccine. https://t.co/lctVfAHV1e https://t.co/Wc91UF86gQ
-
First study to detect #DeltaVariant of SARS-CoV-2 in maternal bloodstream and placenta in cases of #Stillbirth and #PregnancyComplications Andrea Edlow, MD Maternal-Fetal Medicine, @MassGeneralNews https://t.co/oHjNhl3T7L https://t.co/r7ELEzJRR4